Clinical Trials Logo

Labour;Obstructed clinical trials

View clinical trials related to Labour;Obstructed.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04741698 Completed - Labor Dystocia Clinical Trials

Propranolol for Protracted Labor

PRO-Labor
Start date: July 27, 2021
Phase: Phase 1
Study type: Interventional

Induction of labor is one of the most common procedures performed on labor and delivery. In the United States, more than 20 percent of pregnant women undergo an induction of labor [1]. There is data from small, randomized studies that demonstrates the effectiveness of propranolol, a non-selective beta-blocker, for labor augmentation. This literature suggests a decrease in the amount of time to delivery and a possible reduction in cesarean section rates when propranolol is used in conjunction with oxytocin for induction of labor compared to oxytocin alone [2-8]. Alpha- and beta-adrenergic receptors have been identified in the human myometrium. Propranolol has been shown in studies to enhance uterine contractions and may be a useful tool in this population of women. Therefore, the purpose of this study is to assess whether the administration of propranolol at time of labor dystocia reduces time to delivery.

NCT ID: NCT04210908 Completed - Labor Long Clinical Trials

Biofeedback for Second Stage of Labor

Start date: April 30, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to examine whether transperineal ultrasound as visual biofeedback can be used during labor as an effective tool for shortening the second stage of labor and reducing the need for instrumental delivery, in a prospective randomized design.